KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to -$19.0 million.

  • BeOne Medicines' Other Non Operating Income fell 26768.86% to -$19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.6 million, marking a year-over-year decrease of 21541.61%. This contributed to the annual value of -$12.6 million for FY2024, which is 10410.47% down from last year.
  • BeOne Medicines' Other Non Operating Income amounted to -$19.0 million in Q3 2025, which was down 26768.86% from $8.2 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Other Non Operating Income ranged from a high of $336.7 million in Q3 2023 and a low of -$800.2 million during Q4 2021
  • Over the past 5 years, BeOne Medicines' median Other Non Operating Income value was $1.8 million (recorded in 2024), while the average stood at -$37.3 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 45116.44% in 2021, then tumbled by 1485005.77% in 2022.
  • BeOne Medicines' Other Non Operating Income (Quarter) stood at -$800.2 million in 2021, then skyrocketed by 102.43% to $19.4 million in 2022, then dropped by 13.83% to $16.7 million in 2023, then plummeted by 182.0% to -$13.7 million in 2024, then tumbled by 38.19% to -$19.0 million in 2025.
  • Its Other Non Operating Income was -$19.0 million in Q3 2025, compared to $8.2 million in Q2 2025 and $4.0 million in Q1 2025.